NCT03087786View on ClinicalTrials.gov

Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

August 13, 2017

Study Completion Date

August 13, 2017

Conditions
Safety Issues
Interventions
DRUG

Nicotine Bitartrate Lozenge 4mg

Test Product

DRUG

Nicotine Polacrilex 4Mg Lozenge

Active Comparator

Trial Locations (1)

07105

Inflamax Research Inc, Newark

All Listed Sponsors
collaborator

Inflamax Research Incorporated

INDUSTRY

lead

Niconovum USA

INDUSTRY

NCT03087786 - Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations | Biotech Hunter | Biotech Hunter